Join us at the HKBMIA Association + Spring Dinner, where we’ll be on hand to discuss how Synexa supports biomedical innovation across Asia with advanced biomarker and bioanalytical capabilities.
The Hong Kong Bio‑Med Innotech Association (HKBMIA), an organisation committed to establishing an innovative and international biomedical technology hub in Hong Kong, focuses on supporting biomedical innovation projects, assisting with R&D, commercial development and industry collaboration across the region.
At Synexa, we work closely with partners who require high‑quality scientific insights across the development pathway, from custom assay development, immunology‑focused bioanalysis, and LC‑MS/MS expertise, to strategic biomarker planning for clinical and preclinical programmes.
Explore our capabilities:
Attending from Synexa will be:
- Clara Ip, Business Growth and Alliances-APAC – LinkedIn
- Justin Devine, Co-founder and Senior Director – LinkedIn
To set up a meeting with us at the event, connect with our team on LinkedIn or write to us at contactus@synexagroup.com.
